THE WOODLANDS, Texas--(BUSINESS WIRE)--VGX Animal Health Inc. (VGXAH) and its parent company, VGX Pharmaceuticals (VGXP), announced today the execution of an exclusive Distribution and Marketing Agreement for its LifeTide™ SW 5 GHRH gene therapy product for pigs in Australia with Country Vet Wholesaling Pty Ltd (CVW). Under the Agreement, CVW has the exclusive right to market, promote, sell and distribute the Product in Australia.